These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1512 related items for PubMed ID: 22712644
1. Molecular imaging of dementia. Mori T, Maeda J, Shimada H, Higuchi M, Shinotoh H, Ueno S, Suhara T. Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644 [Abstract] [Full Text] [Related]
2. PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies. Gomperts SN, Marquie M, Locascio JJ, Bayer S, Johnson KA, Growdon JH. Neurodegener Dis; 2016 Jun; 16(1-2):118-24. PubMed ID: 26655867 [Abstract] [Full Text] [Related]
3. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. Pontecorvo MJ, Devous MD, Navitsky M, Lu M, Salloway S, Schaerf FW, Jennings D, Arora AK, McGeehan A, Lim NC, Xiong H, Joshi AD, Siderowf A, Mintun MA, 18F-AV-1451-A05 investigators. Brain; 2017 Mar 01; 140(3):748-763. PubMed ID: 28077397 [Abstract] [Full Text] [Related]
4. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease. Kerbler GM, Fripp J, Rowe CC, Villemagne VL, Salvado O, Rose S, Coulson EJ, Alzheimer's Disease Neuroimaging Initiative. Neuroimage Clin; 2015 Mar 01; 7():105-13. PubMed ID: 25610772 [Abstract] [Full Text] [Related]
5. Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases. Lee SH, Cho H, Choi JY, Lee JH, Ryu YH, Lee MS, Lyoo CH. Mov Disord; 2018 Feb 01; 33(2):262-272. PubMed ID: 29168583 [Abstract] [Full Text] [Related]
6. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging. Zhao Y, Raichle ME, Wen J, Benzinger TL, Fagan AM, Hassenstab J, Vlassenko AG, Luo J, Cairns NJ, Christensen JJ, Morris JC, Yablonskiy DA. Neuroimage; 2017 Mar 01; 148():296-304. PubMed ID: 27989773 [Abstract] [Full Text] [Related]
7. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study. Villain N, Chételat G, Grassiot B, Bourgeat P, Jones G, Ellis KA, Ames D, Martins RN, Eustache F, Salvado O, Masters CL, Rowe CC, Villemagne VL, AIBL Research Group. Brain; 2012 Jul 01; 135(Pt 7):2126-39. PubMed ID: 22628162 [Abstract] [Full Text] [Related]
8. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease. Chen CJ, Bando K, Ashino H, Taguchi K, Shiraishi H, Shima K, Fujimoto O, Kitamura C, Matsushima S, Uchida K, Nakahara Y, Kasahara H, Minamizawa T, Jiang C, Zhang MR, Ono M, Tokunaga M, Suhara T, Higuchi M, Yamada K, Ji B. J Nucl Med; 2015 Jan 01; 56(1):120-6. PubMed ID: 25476539 [Abstract] [Full Text] [Related]
9. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology. Okada H, Ouchi Y, Ogawa M, Futatsubashi M, Saito Y, Yoshikawa E, Terada T, Oboshi Y, Tsukada H, Ueki T, Watanabe M, Yamashita T, Magata Y. Brain; 2013 Oct 01; 136(Pt 10):3004-17. PubMed ID: 23975517 [Abstract] [Full Text] [Related]
10. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy. Tateno A, Sakayori T, Kawashima Y, Higuchi M, Suhara T, Mizumura S, Mintun MA, Skovronsky DM, Honjo K, Ishihara K, Kumita S, Suzuki H, Okubo Y. Int J Geriatr Psychiatry; 2015 May 01; 30(5):505-13. PubMed ID: 25043833 [Abstract] [Full Text] [Related]
11. Testing and disclosures related to amyloid imaging and Alzheimer's disease: Common questions and fact sheet summary. Rabinovici GD, Karlawish J, Knopman D, Snyder HM, Sperling R, Carrillo MC. Alzheimers Dement; 2016 Apr 01; 12(4):510-5. PubMed ID: 27103054 [Abstract] [Full Text] [Related]
12. Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment. Mattsson N, Tosun D, Insel PS, Simonson A, Jack CR, Beckett LA, Donohue M, Jagust W, Schuff N, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. Brain; 2014 May 01; 137(Pt 5):1550-61. PubMed ID: 24625697 [Abstract] [Full Text] [Related]
13. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain]. Watanabe H. Yakugaku Zasshi; 2017 May 01; 137(11):1361-1365. PubMed ID: 29093372 [Abstract] [Full Text] [Related]
14. In vivo positron emission tomographic imaging of glial responses to amyloid-beta and tau pathologies in mouse models of Alzheimer's disease and related disorders. Maeda J, Zhang MR, Okauchi T, Ji B, Ono M, Hattori S, Kumata K, Iwata N, Saido TC, Trojanowski JQ, Lee VM, Staufenbiel M, Tomiyama T, Mori H, Fukumura T, Suhara T, Higuchi M. J Neurosci; 2011 Mar 23; 31(12):4720-30. PubMed ID: 21430171 [Abstract] [Full Text] [Related]
15. Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm. Chiotis K, Saint-Aubert L, Savitcheva I, Jelic V, Andersen P, Jonasson M, Eriksson J, Lubberink M, Almkvist O, Wall A, Antoni G, Nordberg A. Eur J Nucl Med Mol Imaging; 2016 Aug 23; 43(9):1686-99. PubMed ID: 26996778 [Abstract] [Full Text] [Related]
18. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum. Sierra M, Gelpi E, Martí MJ, Compta Y. Neuropathol Appl Neurobiol; 2016 Aug 23; 42(5):451-62. PubMed ID: 26810462 [Abstract] [Full Text] [Related]